 | • レポートコード：MRC2-11QY11978 • 出版社/出版日：QYResearch / 2020年11月25日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、99ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は濾胞性リンパ腫治療のグローバル市場について調査・分析したレポートです。種類別（化学療法、放射線療法、モノクローナル抗体、幹細胞移植）市場規模、用途別（病院、クリニック、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別濾胞性リンパ腫治療の競争状況、市場シェア ・世界の濾胞性リンパ腫治療市場：種類別市場規模 2015年-2020年（化学療法、放射線療法、モノクローナル抗体、幹細胞移植） ・世界の濾胞性リンパ腫治療市場：種類別市場規模予測 2021年-2026年（化学療法、放射線療法、モノクローナル抗体、幹細胞移植） ・世界の濾胞性リンパ腫治療市場：用途別市場規模 2015年-2020年（病院、クリニック、その他） ・世界の濾胞性リンパ腫治療市場：用途別市場規模予測 2021年-2026年（病院、クリニック、その他） ・北米の濾胞性リンパ腫治療市場分析：米国、カナダ ・ヨーロッパの濾胞性リンパ腫治療市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの濾胞性リンパ腫治療市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の濾胞性リンパ腫治療市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの濾胞性リンパ腫治療市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Bayer、Biogen、F. Hoffmann-La Roche、Gilead、Merck、Celldex、Boehringer Ingelheim、Bristol-Myers Squibb ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Follicular lymphoma is a type of blood cancer. It is the most common of the indolent (slow-growing) non-Hodgkin’s lymphomas, and the second-most-common form of non-Hodgkin’s lymphomas overall. It is defined as a lymphoma of follicle center B-cells (centrocytes and centroblasts), which has at least a partially follicular pattern.
Market Analysis and Insights: Global Follicular Lymphoma Therapeutic Market
The global Follicular Lymphoma Therapeutic market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Follicular Lymphoma Therapeutic Scope and Market Size
Follicular Lymphoma Therapeutic market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Follicular Lymphoma Therapeutic market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Bayer
Biogen
F. Hoffmann-La Roche
Gilead
Merck
Celldex
Boehringer Ingelheim
Bristol-Myers Squibb
Market segment by Type, the product can be split into
Chemotherapy
Radiotherapy
Monoclonal Antibodies
Stem Cell Transplantation
Market segment by Application, split into
Hospital
Clinic
Others
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Follicular Lymphoma Therapeutic Revenue
1.4 Market by Type
1.4.1 Global Follicular Lymphoma Therapeutic Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Chemotherapy
1.4.3 Radiotherapy
1.4.4 Monoclonal Antibodies
1.4.5 Stem Cell Transplantation
1.5 Market by Application
1.5.1 Global Follicular Lymphoma Therapeutic Market Share by Application: 2020 VS 2026
1.5.2 Hospital
1.5.3 Clinic
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Follicular Lymphoma Therapeutic Market Perspective (2015-2026)
2.2 Global Follicular Lymphoma Therapeutic Growth Trends by Regions
2.2.1 Follicular Lymphoma Therapeutic Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Follicular Lymphoma Therapeutic Historic Market Share by Regions (2015-2020)
2.2.3 Follicular Lymphoma Therapeutic Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Follicular Lymphoma Therapeutic Market Growth Strategy
2.3.6 Primary Interviews with Key Follicular Lymphoma Therapeutic Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Follicular Lymphoma Therapeutic Players by Market Size
3.1.1 Global Top Follicular Lymphoma Therapeutic Players by Revenue (2015-2020)
3.1.2 Global Follicular Lymphoma Therapeutic Revenue Market Share by Players (2015-2020)
3.1.3 Global Follicular Lymphoma Therapeutic Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Follicular Lymphoma Therapeutic Market Concentration Ratio
3.2.1 Global Follicular Lymphoma Therapeutic Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Follicular Lymphoma Therapeutic Revenue in 2019
3.3 Follicular Lymphoma Therapeutic Key Players Head office and Area Served
3.4 Key Players Follicular Lymphoma Therapeutic Product Solution and Service
3.5 Date of Enter into Follicular Lymphoma Therapeutic Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Follicular Lymphoma Therapeutic Historic Market Size by Type (2015-2020)
4.2 Global Follicular Lymphoma Therapeutic Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Follicular Lymphoma Therapeutic Market Size by Application (2015-2020)
5.2 Global Follicular Lymphoma Therapeutic Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Follicular Lymphoma Therapeutic Market Size (2015-2020)
6.2 Follicular Lymphoma Therapeutic Key Players in North America (2019-2020)
6.3 North America Follicular Lymphoma Therapeutic Market Size by Type (2015-2020)
6.4 North America Follicular Lymphoma Therapeutic Market Size by Application (2015-2020)
7 Europe
7.1 Europe Follicular Lymphoma Therapeutic Market Size (2015-2020)
7.2 Follicular Lymphoma Therapeutic Key Players in Europe (2019-2020)
7.3 Europe Follicular Lymphoma Therapeutic Market Size by Type (2015-2020)
7.4 Europe Follicular Lymphoma Therapeutic Market Size by Application (2015-2020)
8 China
8.1 China Follicular Lymphoma Therapeutic Market Size (2015-2020)
8.2 Follicular Lymphoma Therapeutic Key Players in China (2019-2020)
8.3 China Follicular Lymphoma Therapeutic Market Size by Type (2015-2020)
8.4 China Follicular Lymphoma Therapeutic Market Size by Application (2015-2020)
9 Japan
9.1 Japan Follicular Lymphoma Therapeutic Market Size (2015-2020)
9.2 Follicular Lymphoma Therapeutic Key Players in Japan (2019-2020)
9.3 Japan Follicular Lymphoma Therapeutic Market Size by Type (2015-2020)
9.4 Japan Follicular Lymphoma Therapeutic Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Follicular Lymphoma Therapeutic Market Size (2015-2020)
10.2 Follicular Lymphoma Therapeutic Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Follicular Lymphoma Therapeutic Market Size by Type (2015-2020)
10.4 Southeast Asia Follicular Lymphoma Therapeutic Market Size by Application (2015-2020)
11 India
11.1 India Follicular Lymphoma Therapeutic Market Size (2015-2020)
11.2 Follicular Lymphoma Therapeutic Key Players in India (2019-2020)
11.3 India Follicular Lymphoma Therapeutic Market Size by Type (2015-2020)
11.4 India Follicular Lymphoma Therapeutic Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Follicular Lymphoma Therapeutic Market Size (2015-2020)
12.2 Follicular Lymphoma Therapeutic Key Players in Central & South America (2019-2020)
12.3 Central & South America Follicular Lymphoma Therapeutic Market Size by Type (2015-2020)
12.4 Central & South America Follicular Lymphoma Therapeutic Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Bayer
13.1.1 Bayer Company Details
13.1.2 Bayer Business Overview
13.1.3 Bayer Follicular Lymphoma Therapeutic Introduction
13.1.4 Bayer Revenue in Follicular Lymphoma Therapeutic Business (2015-2020))
13.1.5 Bayer Recent Development
13.2 Biogen
13.2.1 Biogen Company Details
13.2.2 Biogen Business Overview
13.2.3 Biogen Follicular Lymphoma Therapeutic Introduction
13.2.4 Biogen Revenue in Follicular Lymphoma Therapeutic Business (2015-2020)
13.2.5 Biogen Recent Development
13.3 F. Hoffmann-La Roche
13.3.1 F. Hoffmann-La Roche Company Details
13.3.2 F. Hoffmann-La Roche Business Overview
13.3.3 F. Hoffmann-La Roche Follicular Lymphoma Therapeutic Introduction
13.3.4 F. Hoffmann-La Roche Revenue in Follicular Lymphoma Therapeutic Business (2015-2020)
13.3.5 F. Hoffmann-La Roche Recent Development
13.4 Gilead
13.4.1 Gilead Company Details
13.4.2 Gilead Business Overview
13.4.3 Gilead Follicular Lymphoma Therapeutic Introduction
13.4.4 Gilead Revenue in Follicular Lymphoma Therapeutic Business (2015-2020)
13.4.5 Gilead Recent Development
13.5 Merck
13.5.1 Merck Company Details
13.5.2 Merck Business Overview
13.5.3 Merck Follicular Lymphoma Therapeutic Introduction
13.5.4 Merck Revenue in Follicular Lymphoma Therapeutic Business (2015-2020)
13.5.5 Merck Recent Development
13.6 Celldex
13.6.1 Celldex Company Details
13.6.2 Celldex Business Overview
13.6.3 Celldex Follicular Lymphoma Therapeutic Introduction
13.6.4 Celldex Revenue in Follicular Lymphoma Therapeutic Business (2015-2020)
13.6.5 Celldex Recent Development
13.7 Boehringer Ingelheim
13.7.1 Boehringer Ingelheim Company Details
13.7.2 Boehringer Ingelheim Business Overview
13.7.3 Boehringer Ingelheim Follicular Lymphoma Therapeutic Introduction
13.7.4 Boehringer Ingelheim Revenue in Follicular Lymphoma Therapeutic Business (2015-2020)
13.7.5 Boehringer Ingelheim Recent Development
13.8 Bristol-Myers Squibb
13.8.1 Bristol-Myers Squibb Company Details
13.8.2 Bristol-Myers Squibb Business Overview
13.8.3 Bristol-Myers Squibb Follicular Lymphoma Therapeutic Introduction
13.8.4 Bristol-Myers Squibb Revenue in Follicular Lymphoma Therapeutic Business (2015-2020)
13.8.5 Bristol-Myers Squibb Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Follicular Lymphoma Therapeutic Key Market Segments
Table 2. Key Players Covered: Ranking by Follicular Lymphoma Therapeutic Revenue
Table 3. Ranking of Global Top Follicular Lymphoma Therapeutic Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Follicular Lymphoma Therapeutic Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Chemotherapy
Table 6. Key Players of Radiotherapy
Table 7. Key Players of Monoclonal Antibodies
Table 8. Key Players of Stem Cell Transplantation
Table 9. Global Follicular Lymphoma Therapeutic Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 10. Global Follicular Lymphoma Therapeutic Market Size by Regions (US$ Million): 2020 VS 2026
Table 11. Global Follicular Lymphoma Therapeutic Market Size by Regions (2015-2020) (US$ Million)
Table 12. Global Follicular Lymphoma Therapeutic Market Share by Regions (2015-2020)
Table 13. Global Follicular Lymphoma Therapeutic Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 14. Global Follicular Lymphoma Therapeutic Market Share by Regions (2021-2026)
Table 15. Market Top Trends
Table 16. Key Drivers: Impact Analysis
Table 17. Key Challenges
Table 18. Follicular Lymphoma Therapeutic Market Growth Strategy
Table 19. Main Points Interviewed from Key Follicular Lymphoma Therapeutic Players
Table 20. Global Follicular Lymphoma Therapeutic Revenue by Players (2015-2020) (Million US$)
Table 21. Global Follicular Lymphoma Therapeutic Market Share by Players (2015-2020)
Table 22. Global Top Follicular Lymphoma Therapeutic Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Follicular Lymphoma Therapeutic as of 2019)
Table 23. Global Follicular Lymphoma Therapeutic by Players Market Concentration Ratio (CR5 and HHI)
Table 24. Key Players Headquarters and Area Served
Table 25. Key Players Follicular Lymphoma Therapeutic Product Solution and Service
Table 26. Date of Enter into Follicular Lymphoma Therapeutic Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Follicular Lymphoma Therapeutic Market Size by Type (2015-2020) (Million US$)
Table 29. Global Follicular Lymphoma Therapeutic Market Size Share by Type (2015-2020)
Table 30. Global Follicular Lymphoma Therapeutic Revenue Market Share by Type (2021-2026)
Table 31. Global Follicular Lymphoma Therapeutic Market Size Share by Application (2015-2020)
Table 32. Global Follicular Lymphoma Therapeutic Market Size by Application (2015-2020) (Million US$)
Table 33. Global Follicular Lymphoma Therapeutic Market Size Share by Application (2021-2026)
Table 34. North America Key Players Follicular Lymphoma Therapeutic Revenue (2019-2020) (Million US$)
Table 35. North America Key Players Follicular Lymphoma Therapeutic Market Share (2019-2020)
Table 36. North America Follicular Lymphoma Therapeutic Market Size by Type (2015-2020) (Million US$)
Table 37. North America Follicular Lymphoma Therapeutic Market Share by Type (2015-2020)
Table 38. North America Follicular Lymphoma Therapeutic Market Size by Application (2015-2020) (Million US$)
Table 39. North America Follicular Lymphoma Therapeutic Market Share by Application (2015-2020)
Table 40. Europe Key Players Follicular Lymphoma Therapeutic Revenue (2019-2020) (Million US$)
Table 41. Europe Key Players Follicular Lymphoma Therapeutic Market Share (2019-2020)
Table 42. Europe Follicular Lymphoma Therapeutic Market Size by Type (2015-2020) (Million US$)
Table 43. Europe Follicular Lymphoma Therapeutic Market Share by Type (2015-2020)
Table 44. Europe Follicular Lymphoma Therapeutic Market Size by Application (2015-2020) (Million US$)
Table 45. Europe Follicular Lymphoma Therapeutic Market Share by Application (2015-2020)
Table 46. China Key Players Follicular Lymphoma Therapeutic Revenue (2019-2020) (Million US$)
Table 47. China Key Players Follicular Lymphoma Therapeutic Market Share (2019-2020)
Table 48. China Follicular Lymphoma Therapeutic Market Size by Type (2015-2020) (Million US$)
Table 49. China Follicular Lymphoma Therapeutic Market Share by Type (2015-2020)
Table 50. China Follicular Lymphoma Therapeutic Market Size by Application (2015-2020) (Million US$)
Table 51. China Follicular Lymphoma Therapeutic Market Share by Application (2015-2020)
Table 52. Japan Key Players Follicular Lymphoma Therapeutic Revenue (2019-2020) (Million US$)
Table 53. Japan Key Players Follicular Lymphoma Therapeutic Market Share (2019-2020)
Table 54. Japan Follicular Lymphoma Therapeutic Market Size by Type (2015-2020) (Million US$)
Table 55. Japan Follicular Lymphoma Therapeutic Market Share by Type (2015-2020)
Table 56. Japan Follicular Lymphoma Therapeutic Market Size by Application (2015-2020) (Million US$)
Table 57. Japan Follicular Lymphoma Therapeutic Market Share by Application (2015-2020)
Table 58. Southeast Asia Key Players Follicular Lymphoma Therapeutic Revenue (2019-2020) (Million US$)
Table 59. Southeast Asia Key Players Follicular Lymphoma Therapeutic Market Share (2019-2020)
Table 60. Southeast Asia Follicular Lymphoma Therapeutic Market Size by Type (2015-2020) (Million US$)
Table 61. Southeast Asia Follicular Lymphoma Therapeutic Market Share by Type (2015-2020)
Table 62. Southeast Asia Follicular Lymphoma Therapeutic Market Size by Application (2015-2020) (Million US$)
Table 63. Southeast Asia Follicular Lymphoma Therapeutic Market Share by Application (2015-2020)
Table 64. India Key Players Follicular Lymphoma Therapeutic Revenue (2019-2020) (Million US$)
Table 65. India Key Players Follicular Lymphoma Therapeutic Market Share (2019-2020)
Table 66. India Follicular Lymphoma Therapeutic Market Size by Type (2015-2020) (Million US$)
Table 67. India Follicular Lymphoma Therapeutic Market Share by Type (2015-2020)
Table 68. India Follicular Lymphoma Therapeutic Market Size by Application (2015-2020) (Million US$)
Table 69. India Follicular Lymphoma Therapeutic Market Share by Application (2015-2020)
Table 70. Central & South America Key Players Follicular Lymphoma Therapeutic Revenue (2019-2020) (Million US$)
Table 71. Central & South America Key Players Follicular Lymphoma Therapeutic Market Share (2019-2020)
Table 72. Central & South America Follicular Lymphoma Therapeutic Market Size by Type (2015-2020) (Million US$)
Table 73. Central & South America Follicular Lymphoma Therapeutic Market Share by Type (2015-2020)
Table 74. Central & South America Follicular Lymphoma Therapeutic Market Size by Application (2015-2020) (Million US$)
Table 75. Central & South America Follicular Lymphoma Therapeutic Market Share by Application (2015-2020)
Table 76. Bayer Company Details
Table 77. Bayer Business Overview
Table 78. Bayer Product
Table 79. Bayer Revenue in Follicular Lymphoma Therapeutic Business (2015-2020) (Million US$)
Table 80. Bayer Recent Development
Table 81. Biogen Company Details
Table 82. Biogen Business Overview
Table 83. Biogen Product
Table 84. Biogen Revenue in Follicular Lymphoma Therapeutic Business (2015-2020) (Million US$)
Table 85. Biogen Recent Development
Table 86. F. Hoffmann-La Roche Company Details
Table 87. F. Hoffmann-La Roche Business Overview
Table 88. F. Hoffmann-La Roche Product
Table 89. F. Hoffmann-La Roche Revenue in Follicular Lymphoma Therapeutic Business (2015-2020) (Million US$)
Table 90. F. Hoffmann-La Roche Recent Development
Table 91. Gilead Company Details
Table 92. Gilead Business Overview
Table 93. Gilead Product
Table 94. Gilead Revenue in Follicular Lymphoma Therapeutic Business (2015-2020) (Million US$)
Table 95. Gilead Recent Development
Table 96. Merck Company Details
Table 97. Merck Business Overview
Table 98. Merck Product
Table 99. Merck Revenue in Follicular Lymphoma Therapeutic Business (2015-2020) (Million US$)
Table 100. Merck Recent Development
Table 101. Celldex Company Details
Table 102. Celldex Business Overview
Table 103. Celldex Product
Table 104. Celldex Revenue in Follicular Lymphoma Therapeutic Business (2015-2020) (Million US$)
Table 105. Celldex Recent Development
Table 106. Boehringer Ingelheim Company Details
Table 107. Boehringer Ingelheim Business Overview
Table 108. Boehringer Ingelheim Product
Table 109. Boehringer Ingelheim Revenue in Follicular Lymphoma Therapeutic Business (2015-2020) (Million US$)
Table 110. Boehringer Ingelheim Recent Development
Table 111. Bristol-Myers Squibb Business Overview
Table 112. Bristol-Myers Squibb Product
Table 113. Bristol-Myers Squibb Company Details
Table 114. Bristol-Myers Squibb Revenue in Follicular Lymphoma Therapeutic Business (2015-2020) (Million US$)
Table 115. Bristol-Myers Squibb Recent Development
Table 116. Research Programs/Design for This Report
Table 117. Key Data Information from Secondary Sources
Table 118. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Follicular Lymphoma Therapeutic Market Share by Type: 2020 VS 2026
Figure 2. Chemotherapy Features
Figure 3. Radiotherapy Features
Figure 4. Monoclonal Antibodies Features
Figure 5. Stem Cell Transplantation Features
Figure 6. Global Follicular Lymphoma Therapeutic Market Share by Application: 2020 VS 2026
Figure 7. Hospital Case Studies
Figure 8. Clinic Case Studies
Figure 9. Others Case Studies
Figure 10. Follicular Lymphoma Therapeutic Report Years Considered
Figure 11. Global Follicular Lymphoma Therapeutic Market Size YoY Growth 2015-2026 (US$ Million)
Figure 12. Global Follicular Lymphoma Therapeutic Market Share by Regions: 2020 VS 2026
Figure 13. Global Follicular Lymphoma Therapeutic Market Share by Regions (2021-2026)
Figure 14. Porter's Five Forces Analysis
Figure 15. Global Follicular Lymphoma Therapeutic Market Share by Players in 2019
Figure 16. Global Top Follicular Lymphoma Therapeutic Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Follicular Lymphoma Therapeutic as of 2019
Figure 17. The Top 10 and 5 Players Market Share by Follicular Lymphoma Therapeutic Revenue in 2019
Figure 18. North America Follicular Lymphoma Therapeutic Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Europe Follicular Lymphoma Therapeutic Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. China Follicular Lymphoma Therapeutic Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Japan Follicular Lymphoma Therapeutic Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Southeast Asia Follicular Lymphoma Therapeutic Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. India Follicular Lymphoma Therapeutic Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Central & South America Follicular Lymphoma Therapeutic Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Bottom-up and Top-down Approaches for This Report
Figure 26. Data Triangulation
Figure 27. Key Executives Interviewed
リンパ芽球性リンパ腫治療薬の世界市場（～2026年） Lymphoblastic lymphoma (LL) is a rare type of fast-growing non-Hodgkin lymphoma (NHL). It develops when the body makes abnormal lymphocytes. It can develop from both B-cell and T-cell lymphocytes. Lymphocytes are white blood cells that fight infection. Market Analysis and Insights: Global Lymphoblas…- 成人T細胞白血病/リンパ腫治療の世界市場（～2026年） Adult T-cell lymphoma/leukemia (ATL) is a rare T-cell lymphoproliferative neoplasm caused by human T-lymphotrophic virus 1. In its more common, aggressive forms, ATL carries one of the poorest prognoses of the non-Hodgkin lymphomas. The disease has clinical subtypes (ie, acute, lymphoma, chronic, an…
- 毛包単位抽出（FUE）システムの世界市場（～2026年） FUE systems are used in hair transplantation procedures for providing an improved patient experience, while avoiding extensive physician involvement, which eventually leads to a reduction in physician fatigues, increase in procedure efficiency, and increase in the transection rate. In terms of geogr…
- 治療用組換え抗体・タンパク質の世界市場（～2026年） Therapeutic proteins are engineered in the laboratory for pharmaceutical use, including non-covalent binders. These proteins are highly effective and serve as modernized treatment for rare as well as chronic diseases. Protein therapeutics offer custom-made treatment approach by supporting a specific…
- 非ホジキンリンパ腫（NHL）の世界市場（～2026年） Non-Hodgkin Lymphoma is the most common lymphoma which affects large number of people. It begins in lymphocytes present in lymph nodes of body parts such as neck or chest or under the arms. It widely spreads to the other lymph nodes and to other organs such as bone marrow, lungs, or liver. Market An…